Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas

Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas

ABSTRACT Background Bispecific antibodies are effective for relapsed/refractory B‐cell lymphoma patients even after CAR‐T therapy. Methods Peripheral blood CAR‐T kinetics and functional analysis in vivo were carried out pre‐ and post‐epcoritamab infusion in B‐cell lymphoma patients relapsing after C...

Full description

Saved in:
Bibliographic Details
Main Authors: Kensuke Yanashima, Yoshiki Furukawa, Midori Ishii, Shintaro Kinoshita, Yasuharu Hamano, Naoki Watanabe, Yutaka Tsukune, Hajime Yasuda, Jun Ando, Miki Ando
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:eJHaem
Online Access:https://doi.org/10.1002/jha2.70079
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jha2.70079

Similar Items